stage D2 metastatic Carcinoma of the Prostate
stage D2 metastatic Carcinoma of the Prostate is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.
- Classified under
- Indicated drugs
What you can answer from here — as of November 02, 2026
1Indicated drugWith each drug's targets and mechanismListed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for stage D2 metastatic Carcinoma of the Prostate share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account